The central aim of the programme is to ensure enhanced patient care and patient safety with timely, accurate and complete pathology diagnoses and reports.
Launched by the Faculty of Pathology in 2009, the programme aims to:
Thanks to the programme, we can report on national metrics in histopathology, making Ireland the first country in the world to do so.
“Pathology, like many diagnostic services, involves decision making under conditions of uncertainty and an element of error is unavoidable. But an effective quality assurance programme that tracks error rates gives us the best chance to keep them to a minimum.”
Professor Conor O’KeaneConsultant Histopathologist, Mater Misericordiae University Hospital
Diagnostic histopathology involves making diagnoses based on the microscopic examination of tissues removed during various operative interventions and procedures such as endoscopy, biopsy or resections.
The biopsy or surgical specimen is processed and histological sections are placed onto glass slides for examination under a microscope.
Cytopathology deals with diseases on the cellular level. A common application of cytopathology is the smear test, used to detect precancerous cervical lesions and prevent cervical cancer.
The Histopathology National Quality Improvement Programme was developed by the Faculty of Pathology as a matter of priority following high-profile cancer misdiagnosis cases in 2007 and 2008.
The Faculty wanted to systematically produce robust evidence on histopathology services in Ireland against the highest international standards. It also wanted to address the lack of national standards or benchmarks for auditing pathology services.
This programme was known as the National Quality Assurance Programme in Histopathology until February 2015.
“It is a constructive, national, standardised response to concerns raised by events in the past which shows that we do learn from things that have gone wrong.”
Dr Philip CrowleyNational Director of the HSE Quality Improvement Division
This is the fourth annual national produced by the Histopathology QI Programme reporting on quality indicators in histopathology and cytology
The Faculty of Pathology has set evidence based targets so that histopathology laboratories can track their performance in a number of key areas, for example how quickly test results are processed and reported.
Laboratories enter data relating to their performance against these targets in an online quality information system, which then calculates a national average.
Laboratories can see how they are performing compared to the national average and identify if there are issues that need to be addressed or areas in which they are excelling.
Laboratories that are performing better than average are encouraged to share their best practice approach with other laboratories, resulting in improved standards overall.
These guidelines outline quality improvement activities that should be carried out in a Histopathology department. All references to the National Quality Assurance Programme in Histopathology should now be read as the Histopathology National Quality Improvement Programme.
The guidelines were developed by a Working Group of consultant histopathologists appointed by the Faculty of Pathology.
The guidelines have been circulated to all public, private and voluntary hospitals in Ireland that provide histopathology services and are used by all participating histopathology laboratories.
Guidelines for the Histopathology National Quality Improvement Programme
An essential component of the Histopathology National Quality Improvement Programme is an online quality assurance system that was built to store, analyse and report on laboratories’ performance. It was developed by the Faculty of Pathology and HSE Health Intelligence Ireland.
Known as NQAIS (National Quality Assurance Intelligence System), it functions as a central repository for quality improvement data from the Laboratory Information System, LIS. It allows us to generate national reports on the accuracy and timeliness of diagnostic testing in hospital laboratories across Ireland.
All 25 of the public histopathology laboratories and seven private laboratories are currently using NQAIS.
Thanks to NQAIS, laboratories can spot best practice and variations from best practice, and monitor, review and improve the quality of their work in the context of national norms and targets set by the Faculty of Pathology.
We use NQAIS to produce an annual report on national metrics in histopathology, making Ireland the first country in the world to do so.
|Beacon Hospital||Beaumont Hospital||Blackrock Clinic|
|Bon Secours Hospital, Cork||Bon Secours Hospital, Dublin||Bon Secours Hospital, Tralee|
|Cavan & Monaghan Hospital
||Children's University Hospital, Temple St.
||Connolly Hospital Blanchardstown Hospital|
|Coombe Women and Infants University Hospital||Cork University Hospital
|Letterkenny General Hospital
||Mater Misericordiae University Hospital||Mater Private Hospital - Dublin
|Mayo General Hospital General||Midlands Regional Hospital at Tullamore
||Our Lady of Lourdes Hospital, Drogheda
|Our Lady's Children's Hospital, Crumlin||Portiuncula Hospital||Rotunda Hospital|
|Royal Victoria Eye and Ear Hospital||Sligo University Hospital||St. Columcille's Hospital|
|St. James Hospital||St. Vincent's University Hospital||Tallaght Hospital|
|The National Maternity Hospital, Holles St||University Hospital Galway||University Hospital Kerry|
|University Hospital Limerick||University Hospital Waterford|
“NQAIS is a hugely important advance in patient safety and treatment. As in any walk of life, medical error cannot be entirely eliminated, but this system will give Irish laboratories a unique advantage in monitoring the quality of their reporting and reviewing it against the national standard. This will drive improvement and ultimately reduce errors”
Dr Niall SwanConsultant Histopathologist at St Vincent’s Hospital
The Histopathology National Quality Improvement Programme is led by the Faculty of Pathology. It has received wide support and is governed by a Steering Committee with representation from:
"Ireland is the first country in the world to publically report national metrics on the quality of their pathology system. This should help assure the Irish people that important aspects of medical safety and quality continue to be carefully monitored.”
Professor John SrigleyExpert Lead for Pathology, Canadian Partnership Against Cancer
The Histopathology National Quality Improvement Programme won an award for Excellence in Healthcare Management at the Irish Medical Times Healthcare Awards which took place at the Shelbourne Hotel on Thursday, 5 November 2015.The judges commended the programme as a key initiative in enhancing patient safety which has received wide support from organisations within the healthcare sector.Read the full news story
Thank you to all who attended the QI Programme's Annual Participant Workshop on 10 May 2016. The presentations for the day are available below. Please share these with your colleagues.
The Histopathology National Quality Improvement Programme has developed an Information Governance Policy.
This policy defines how data collected for the Programme is governed, processed, stored, accessed and reported on.
All references to the National Quality Assurance Programme in Histopathology contained in these documents refer to the Histopathology National Quality Improvement Programme.
If you have any questions about the Specialty Quality Improvement Programmes, please contact:
Sarah provides project support to National Quality Improvement Programmes in
Philip provides project support to National Quality Improvement Programmes in
Conor manages the National Quality Improvement Programmes in